These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33268699)

  • 1. Pharmaceutical Technology Innovation Strategy Based on the Function of Blood Transport Proteins as DDS Carriers for the Treatment of Intractable Disorders and Cancer.
    Taguchi K
    Biol Pharm Bull; 2020; 43(12):1815-1822. PubMed ID: 33268699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
    Oku N
    Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-Based Nanodevices as Drug Carriers.
    Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
    Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive albumin-based carriers for tumour chemotherapy.
    Shahzad Y; Khan IU; Hussain T; Alamgeer ; Serra CA; Rizvi SA; Gerber M; du Plessis J
    Curr Cancer Drug Targets; 2014; 14(8):752-63. PubMed ID: 25348019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G; Hatakeyama H; Harashima H
    Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making a case for albumin – a highly promising drug-delivery system.
    Merlot AM; Kalinowski DS; Kovacevic Z; Jansson PJ; Lane DJ; Huang ML; Sahni S; Richardson DR
    Future Med Chem; 2015; 7(5):553-6. PubMed ID: 25921396
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery systems using polymer nanoassemblies for cancer treatment.
    Bae Y
    Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
    [No Abstract]   [Full Text] [Related]  

  • 11. Protein-based nanoparticles for drug delivery purposes.
    Martínez-López AL; Pangua C; Reboredo C; Campión R; Morales-Gracia J; Irache JM
    Int J Pharm; 2020 May; 581():119289. PubMed ID: 32243968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.
    Stylianopoulos T
    Ther Deliv; 2013 Apr; 4(4):421-3. PubMed ID: 23557281
    [No Abstract]   [Full Text] [Related]  

  • 13. Albumin-Based Nitric Oxide Traffic System for the Treatment of Intractable Cancers.
    Ishima Y
    Biol Pharm Bull; 2017; 40(2):128-134. PubMed ID: 28154250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing anticancer multitarget metal thiosemicarbazone prodrug based on the nature of binding sites of human serum albumin carrier.
    Yang F; Liang H
    Future Med Chem; 2018 Aug; 10(16):1881-1883. PubMed ID: 29925269
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclodextrin-Based Molecular Accessories for Drug Discovery and Drug Delivery.
    Higashi T
    Chem Pharm Bull (Tokyo); 2019; 67(4):289-298. PubMed ID: 30930430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds.
    Ackova DG; Smilkov K; Bosnakovski D
    Recent Pat Anticancer Drug Discov; 2019; 14(1):19-31. PubMed ID: 30636616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics.
    Sabnis N; Lacko AG
    Ther Deliv; 2012 May; 3(5):599-608. PubMed ID: 22834404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin: a versatile carrier for drug delivery.
    Park K
    J Control Release; 2012 Jan; 157(1):3. PubMed ID: 22119742
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in cancer chemotherapy oriented towards new targets.
    Novotny L; Szekeres T
    Expert Opin Ther Targets; 2005 Apr; 9(2):343-57. PubMed ID: 15934920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.